Alberta source: bounded use
Adults receiving inpatient care in Alberta. The exact source supports acute inpatient assessment and treatment; longitudinal community urate-lowering decisions are outside this summary.
sources for this section:AHS adult inpatient gout
Source-attributed clinical priorities
- Confirm gout clinically and use joint aspiration when septic arthritis or crystal uncertainty would change urgent management.
- Treat acute inflammation promptly with an option selected for kidney function, gastrointestinal and cardiovascular risk, interactions and contraindications.
- Document prior flares, tophi, kidney disease, serum urate and established urate-lowering therapy so discharge follow-up can be handed back explicitly.
- In the hospitalized adult, hyperuricemia alone does not establish gout and an acutely inflamed joint still requires assessment for infection.
sources for this section:AHS adult inpatient gout
Practical assessment and management workflow
1
Document joint pattern, onset, fever, skin breach, prior attacks, tophi, kidney disease and current urate-altering medicines.
2
Aspirate a first, atypical or systemically unwell hot joint when infection or diagnostic uncertainty would change urgent care.
3
Select inpatient flare treatment around renal function, bleeding, cardiovascular risk, infection and interacting medicines.
4
Record clinical response, medicine changes and who will reassess recurrent disease and serum urate after discharge.
sources for this section:AHS adult inpatient gout
Safety, red flags and urgent escalation
- Treat possible septic arthritis as an emergency even when crystals are found.
- Review kidney function, anticoagulation and interacting medicines before colchicine or anti-inflammatory therapy.
- Do not infer a complete community urate-lowering initiation or titration protocol from this inpatient source.
sources for this section:AHS adult inpatient gout
Confirm the local pathway before acting
Alberta is used as an explicit Canadian implementation example, not as a national rule. Verify the equivalent pathway, formulary and escalation route in the patient’s province or territory.
sources for this section:AHS adult inpatient gout
Source and implementation boundary
Read this educational summary with the linked source, current Canadian product information where medicines are involved, and the applicable provincial or territorial pathway. Local formularies, reporting duties, referral routes and service availability can differ.
sources for this section:AHS adult inpatient gout
Source documents
Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.
- Alberta Health ServicesGout, Adult – Inpatient Clinical Knowledge TopicVersion 1.0; exact-topic provincial inpatient source checked 2026-08-20 · accessed 2026-08-20view source
continue the learning
From guidance to deliberate practice and evidence
Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.
Add this guidance review to CPD/CMEOpen an editable learning-log record with this page’s provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what—if anything—you may change. Suggestions are never inserted automatically.Browse the Canada question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.